|
EP1364049A2
(en)
|
2000-07-31 |
2003-11-26 |
Gene Logic, Inc. |
Molecular toxicology modeling
|
|
WO2002022163A1
(en)
*
|
2000-09-13 |
2002-03-21 |
Chugai Seiyaku Kabushiki Kaisha |
Remedies for ischemic diseases
|
|
WO2002046220A2
(en)
*
|
2000-12-07 |
2002-06-13 |
Gencell S.A. |
Sequences upstream of the carp gene, vectors containing them and uses thereof
|
|
US20050124568A1
(en)
|
2001-05-18 |
2005-06-09 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of acetyl-CoA-carboxylase gene expression using short interfering nucleic acid (siNA)
|
|
US6964950B2
(en)
*
|
2001-07-25 |
2005-11-15 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of C-reactive protein expression
|
|
EP2390331B1
(en)
|
2001-09-28 |
2018-04-25 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
MicroRNA molecules
|
|
JP2006502693A
(ja)
|
2002-02-04 |
2006-01-26 |
ジーン ロジック インコーポレイテッド |
初代ラット肝細胞毒性モデリング
|
|
US20080214437A1
(en)
|
2002-09-06 |
2008-09-04 |
Mohapatra Shyam S |
Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
|
|
US7781415B2
(en)
|
2003-02-07 |
2010-08-24 |
Roche Madison Inc. |
Process for delivering sirna to cardiac muscle tissue
|
|
US7683036B2
(en)
|
2003-07-31 |
2010-03-23 |
Regulus Therapeutics Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
|
|
US8106180B2
(en)
|
2003-08-07 |
2012-01-31 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro RNAs
|
|
WO2005017145A1
(ja)
|
2003-08-13 |
2005-02-24 |
Japan Biological Informatics Consortium |
機能性ｒｎａが制御する被制御遺伝子の同定・予測方法及びその利用方法
|
|
US20050256072A1
(en)
|
2004-02-09 |
2005-11-17 |
University Of Massachusetts |
Dual functional oligonucleotides for use in repressing mutant gene expression
|
|
EP2295604B1
(en)
|
2004-02-09 |
2015-04-08 |
Thomas Jefferson University |
Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features
|
|
EP1723162A4
(en)
|
2004-02-13 |
2010-05-05 |
Univ Rockefeller |
ANTI-microRNA oligonucleotide molecules
|
|
EP2290071B1
(en)
|
2004-05-28 |
2014-12-31 |
Asuragen, Inc. |
Methods and compositions involving microRNA
|
|
US7635563B2
(en)
|
2004-06-30 |
2009-12-22 |
Massachusetts Institute Of Technology |
High throughput methods relating to microRNA expression analysis
|
|
WO2006013561A2
(en)
|
2004-08-02 |
2006-02-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions and methods for diagnosing and treating post traumatic stress disorder
|
|
JP2006101790A
(ja)
|
2004-10-06 |
2006-04-20 |
Japan Health Science Foundation |
高血圧症のリスクの評価方法
|
|
WO2006047454A2
(en)
|
2004-10-21 |
2006-05-04 |
Rutgers, The State University Of New Jersey |
Rational probe optimization for detection of micrornas
|
|
CA2857881A1
(en)
|
2004-11-12 |
2006-12-28 |
Asuragen, Inc. |
Methods and compositions involving mirna and mirna inhibitor molecules
|
|
US9550990B2
(en)
|
2004-12-10 |
2017-01-24 |
Ionis Pharmaceuticals, Inc. |
Regulation of epigenetic control of gene expression
|
|
US20060185027A1
(en)
|
2004-12-23 |
2006-08-17 |
David Bartel |
Systems and methods for identifying miRNA targets and for altering miRNA and target expression
|
|
WO2006069584A2
(en)
|
2004-12-29 |
2006-07-06 |
Exiqon A/S |
NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs
|
|
US8071306B2
(en)
|
2005-01-25 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Methods for quantitating small RNA molecules
|
|
EP1874936B1
(en)
|
2005-04-19 |
2013-10-30 |
BASF Plant Science GmbH |
Improved methods controlling gene expression
|
|
PL2002003T3
(pl)
|
2005-05-27 |
2016-06-30 |
Ospedale San Raffaele Srl |
Wektor genetyczny zawierający mi-RNA
|
|
WO2007035684A2
(en)
|
2005-09-16 |
2007-03-29 |
Primera Biosystems, Inc. |
Method for quantitative detection of short rna molecules
|
|
US20070092882A1
(en)
|
2005-10-21 |
2007-04-26 |
Hui Wang |
Analysis of microRNA
|
|
PL1969125T3
(pl)
|
2005-12-12 |
2012-11-30 |
Univ North Carolina Chapel Hill |
Mikrorna, które regulują proliferację i różnicowanie komórek mięśniowych
|
|
EP1966390A1
(en)
|
2005-12-29 |
2008-09-10 |
Exiqon A/S |
Detection of tissue origin of cancer
|
|
EP1984499B1
(en)
|
2006-01-27 |
2015-05-27 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for the use in modulation of micrornas
|
|
CA2648132C
(en)
|
2006-04-03 |
2019-05-28 |
Santaris Pharma A/S |
Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
|
|
KR101485495B1
(ko)
*
|
2006-08-01 |
2015-01-22 |
보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 |
베타-마이오신 중사슬의 발현을 활성화하는 마이크로-ｒｎａ의 동정
|
|
US20090306181A1
(en)
|
2006-09-29 |
2009-12-10 |
Children's Medical Center Corporation |
Compositions and methods for evaluating and treating heart failure
|
|
EP2489742A1
(de)
|
2006-10-09 |
2012-08-22 |
Julius-Maximilians-Universität Würzburg |
MicroRNA (MIRNA) zur Diagnose und Therapie von Herzerkrankungen
|
|
US20100021914A1
(en)
|
2006-11-23 |
2010-01-28 |
Querdenker Aps |
Oligonucleotides for modulating target rna activity
|
|
AU2007334502B2
(en)
|
2006-12-14 |
2011-12-15 |
Novartis Ag |
Compositions and methods to treat muscular & cardiovascular disorders
|
|
EP3536788A1
(en)
|
2006-12-21 |
2019-09-11 |
QIAGEN GmbH |
Microrna target site blocking oligos and uses thereof
|
|
US20090137504A1
(en)
|
2006-12-21 |
2009-05-28 |
Soren Morgenthaler Echwald |
Microrna target site blocking oligos and uses thereof
|
|
WO2008147839A1
(en)
|
2007-05-23 |
2008-12-04 |
Dharmacon, Inc. |
Micro-rna scaffolds and non-naturally occurring micro-rnas
|
|
WO2009018492A2
(en)
*
|
2007-07-31 |
2009-02-05 |
The Board Of Regents Of The University Of Texas System |
Micro-rnas that control myosin expression and myofiber identity
|
|
US20100292099A1
(en)
|
2007-08-23 |
2010-11-18 |
Keren Pharmaceutical, Inc. |
Targeting of rna with external guide sequences
|
|
EP2623599B1
(en)
|
2007-10-04 |
2019-01-02 |
Roche Innovation Center Copenhagen A/S |
Micromirs
|
|
WO2009058818A2
(en)
|
2007-10-29 |
2009-05-07 |
The Board Of Regents Of The University Of Texas System |
Compositions comprising a micro-rna and methods of their use in regulating cardiac remodeling
|
|
JP5654352B2
(ja)
|
2007-11-09 |
2015-01-14 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
ｍｉＲ−１５ファミリーのマイクロＲＮＡによる心筋細胞生存及び心臓修復の調節
|
|
WO2009114681A2
(en)
|
2008-03-13 |
2009-09-17 |
Dharmacon, Inc. |
Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy
|
|
US20090326049A1
(en)
|
2008-04-04 |
2009-12-31 |
Alexander Aristarkhov |
Blocking oligos for inhibition of microrna and sirna activity and uses thereof
|
|
CA2726052A1
(en)
|
2008-06-04 |
2009-12-10 |
The Board Of Regents Of The University Of Texas System |
Modulation of gene expression through endogenous small rna targeting of gene promoters
|
|
AU2009257663B2
(en)
|
2008-06-09 |
2014-06-26 |
New York Medical College |
Compositions comprising cardiac stem cells overexpressing specific microRNA and methods of their use in repairing damaged myocardium
|
|
EP2358398A2
(en)
|
2008-10-24 |
2011-08-24 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|